Geneos Wealth Management’s Enterprise Products Partners EPD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.09M | Buy |
55,340
+495
| +0.9% | +$17.5K | 0.05% | 346 |
|
|
2025
Q4 | $1.76M | Buy |
54,845
+2,727
| +5% | +$86.2K | 0.04% | 379 |
|
|
2025
Q3 | $1.63M | Buy |
52,118
+3,770
| +8% | +$119K | 0.04% | 384 |
|
|
2025
Q2 | $1.5M | Sell |
48,348
-18,166
| -27% | -$566K | 0.04% | 435 |
|
|
2025
Q1 | $2.27M | Buy |
66,514
+40,849
| +159% | +$1.36M | 0.03% | 459 |
|
|
2024
Q4 | $805K | Buy |
25,665
+512
| +2% | +$15.7K | 0.03% | 473 |
|
|
2024
Q3 | $732K | Sell |
25,153
-2,163
| -8% | -$63.2K | 0.03% | 470 |
|
|
2024
Q2 | $792K | Buy |
27,316
+5,544
| +25% | +$159K | 0.04% | 398 |
|
|
2024
Q1 | $635K | Sell |
21,772
-47
| -0.2% | -$1.29K | 0.03% | 437 |
|
|
2023
Q4 | $575K | Sell |
21,819
-7,247
| -25% | -$193K | 0.03% | 447 |
|
|
2023
Q3 | $796K | Sell |
29,066
-1,751
| -6% | -$46.8K | 0.04% | 358 |
|
|
2023
Q2 | $812K | Sell |
30,817
-36,863
| -54% | -$964K | 0.04% | 354 |
|
|
2023
Q1 | $1.75M | Sell |
67,680
-10,474
| -13% | -$269K | 0.11% | 214 |
|
|
2022
Q4 | $1.89M | Buy |
78,154
+10,679
| +16% | +$263K | 0.11% | 187 |
|
|
2022
Q3 | $1.6M | Sell |
67,475
-21,334
| -24% | -$550K | 0.11% | 190 |
|
|
2022
Q2 | $2.19M | Buy |
88,809
+10,802
| +14% | +$284K | 0.11% | 201 |
|
|
2022
Q1 | $2.01M | Buy |
78,007
+8,295
| +12% | +$201K | 0.09% | 222 |
|
|
2021
Q4 | $1.53M | Sell |
69,712
-4,816
| -6% | -$108K | 0.06% | 298 |
|
|
2021
Q3 | $1.62M | Buy |
74,528
+12,398
| +20% | +$282K | 0.06% | 283 |
|
|
2021
Q2 | $1.53M | Sell |
62,130
-61
| -0.1% | -$1.44K | 0.06% | 278 |
|
|
2021
Q1 | $1.43M | Sell |
62,191
-6,856
| -10% | -$151K | 0.04% | 340 |
|
|
2020
Q4 | $1.5M | Sell |
69,047
-2,862
| -4% | -$53.3K | 0.06% | 276 |
|
|
2020
Q3 | $1.11M | Sell |
71,909
-2,728
| -4% | -$47.8K | 0.06% | 271 |
|
|
2020
Q2 | $1.31M | Buy |
74,637
+610
| +0.8% | +$10.9K | 0.07% | 244 |
|
|
2020
Q1 | $1.03M | Sell |
74,027
-1,297
| -2% | -$30.1K | 0.07% | 250 |
|
|
2019
Q4 | $2.12M | Buy |
75,324
+2,105
| +3% | +$57.1K | 0.11% | 195 |
|
|
2019
Q3 | $2.1M | Sell |
73,219
-2,405
| -3% | -$70K | 0.13% | 179 |
|
|
2019
Q2 | $2.18M | Sell |
75,624
-1,720
| -2% | -$49.6K | 0.14% | 165 |
|
|
2019
Q1 | $2.25M | Buy |
77,344
+139
| +0.2% | +$3.88K | 0.15% | 168 |
|
|
2018
Q4 | $1.84M | Buy |
77,205
+1,774
| +2% | +$47.5K | 0.14% | 175 |
|
|
2018
Q3 | $2.17M | Buy |
75,431
+4,283
| +6% | +$124K | 0.14% | 167 |
|
|
2018
Q2 | $1.97M | Sell |
71,148
-11,089
| -13% | -$303K | 0.15% | 147 |
|
|
2018
Q1 | $2.01M | Sell |
82,237
-1,403
| -2% | -$37.4K | 0.18% | 128 |
|
|
2017
Q4 | $2.22M | Buy |
83,640
+19,722
| +31% | +$499K | 0.2% | 125 |
|
|
2017
Q3 | $1.67M | Sell |
63,918
-71
| -0.1% | -$1.88K | 0.17% | 139 |
|
|
2017
Q2 | $1.73M | Sell |
63,989
-3,503
| -5% | -$94.9K | 0.18% | 129 |
|
|
2017
Q1 | $1.86M | Buy |
67,492
+2,999
| +5% | +$83.8K | 0.19% | 116 |
|
|
2016
Q4 | $1.74M | Buy |
64,493
+4,725
| +8% | +$123K | 0.23% | 106 |
|
|
2016
Q3 | $1.65M | Sell |
59,768
-2,506
| -4% | -$69.2K | 0.22% | 108 |
|
|
2016
Q2 | $1.81M | Buy |
62,274
+726
| +1% | +$19.5K | 0.26% | 92 |
|
|
2016
Q1 | $1.49M | Buy |
+61,548
| New | +$1.43M | 0.23% | 109 |
|
Other funds holding EPD
AA
TCA
EIP
KACA
Geneos Wealth Management's EPD Position: Q1 2026 in Review
Geneos Wealth Management increased its Enterprise Products Partners (EPD) stake by 0.9% in Q1 2026, buying an estimated $17.5K and bringing the position to 55,340 shares worth $2.09M. The position accounts for 0.05% of the portfolio, ranked #346.
Geneos Wealth Management first reported a position in EPD in Q1 2016 and has held it in 41 quarters since. The position peaked at $2.27M in Q1 2025. 1,607 funds tracked by Wall St. Rank hold EPD as of Q1 2026.
- Geneos Wealth Management held 55,340 shares of Enterprise Products Partners worth $2.09M as of Q1 2026.
- Geneos Wealth Management bought 495 Enterprise Products Partners shares in Q1 2026, an estimated $17.5K.
- Enterprise Products Partners made up 0.05% of Geneos Wealth Management's portfolio in Q1 2026, its #346 holding.
- Geneos Wealth Management first reported a position in Enterprise Products Partners in Q1 2016 and has held it in 41 quarters since.
- Geneos Wealth Management's Enterprise Products Partners position peaked at $2.27M in Q1 2025.
- 1,607 funds tracked by Wall St. Rank held Enterprise Products Partners as of Q1 2026.
Based on Geneos Wealth Management's 13F filing for Q1 2026, filed 5 May 2026.